Skip to content

Perpetuum Ventures

Active
Public limited companyfounded 20188 yrs activeSmedenstraat 20, 2610 Antwerpen, BelgiumKBO/BCE: BE 0688.603.196

Perpetuum Ventures has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €195k and a net result of €85k. Equity is growing by ~21.9% per year across the filed fiscal years. Its solvency ranks better than 34% of 4827 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
62 / 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability86=
Solvency56▼-27
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity ample (current ratio 1.74 against 3.27 in 2024; short-term debt: 42.9% and cash: 3.4% of total assets), but 69% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
31%
Return on assets
13.5%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
4 d early
2024
1 d early
2023
36 d early
2022
4 d early
2021
27 d early
2020
1 d early
2019
4 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€85k▼ 25.1%
2024 · €114k
2018: €26k 2019: €102k 2020: €53k 2021: €72k 2022: €35k 2023: €118k 2024: €114k
2018 → 2025
Working capital
€200k▼ 59.1%
2024 · €489k
2018: €21k 2019: €154k 2020: €202k 2021: €275k 2022: €311k 2023: €513k 2024: €489k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€353k-€389k▲ 10.0%€507k▲ 30.3%€485k▼ 4.2%€195k▼ 59.8%
Operating result€84k-€42k▼ 50.6%€146k▲ 251%€139k▼ 4.6%€106k▼ 23.7%
Net result€72k-€35k▼ 50.9%€118k▲ 234%€114k▼ 3.6%€85k▼ 25.1%
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €84k€84kNet result 2021: €72k€72kOperating result 2022: €42k€42kNet result 2022: €35k€35kOperating result 2023: €146k€146kNet result 2023: €118k€118kOperating result 2024: €139k€139kNet result 2024: €114k€114kOperating result 2025: €106k€106kNet result 2025: €85k€85k20212022202320242025
The operating result has fallen two years in a row; 2025 is 24% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €629k
Fixed assets €159k▲ 22.6%
Current assets €470k▼ 33.3%
Equity and liabilities €629k
Equity €195k▼ 59.8%
Debt €434k▲ 24.4%
The debt ratio rises from 41.8% to 69.0%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€113k
2024 · €145k
Cash flow
€92k
2024 · €119k
Solvency
31.0%
2024 · 58.2%
Current ratio
1.74
2024 · 3.27
Quick ratio
1.74
2024 · 3.27
Debt / equity
2.22
2024 · 0.72
ROE
43.6%
2024 · 23.4%
ROA
13.5%
2024 · 13.6%
Interest coverage
17.19
2024 · 37.61
Debt
€434k
2024 · €349k
Debt ≤ 1 year
€270k
2024 · €215k
Debt > 1 year
€164k
2024 · €134k
Income taxes
€24k
2024 · €36k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€835k€629k
Fixed assets21/28€130k€159k
Intangible fixed assets21€9k€9k
Tangible fixed assets22/27€5k€11k
Furniture and vehicles24€5k€7k
Other tangible fixed assets26-€4k
Financial fixed assets28€115k€140k
Current assets29/58€705k€470k
Amounts receivable after more than one year29€296k€216k
Trade receivables290€296k€216k
Amounts receivable within one year40/41€406k€208k
Trade receivables40€288k€194k
Other amounts receivable41€118k€14k
Cash at bank and in hand54/58€184€21k
Deferred charges and accrued income490/1€3k€25k
Equity and liabilities
Total equity and liabilities10/49€835k€629k
Equity10/15€485k€195k
Contributions10/11€100k€100k=
Capital10€100k€100k=
Issued capital100€100k€100k=
Reserves13€385k€95k
Non-distributable reserves130/1€10k€10k=
Legal reserve130€10k€10k=
Distributable reserves133€375k€85k
Amounts payable17/49€349k€434k
Amounts payable after more than one year17€134k€164k
Financial debts170/4€134k€164k
Amounts payable within one year42/48€215k€270k
Financial debts43€757€1k
Credit institutions430/8€757€1k
Trade debts44€5k€2k
Suppliers440/4€5k€2k
Taxes, remuneration and social security45€74k€33k
Taxes450/3€74k€33k
Other amounts payable47/48€136k€234k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€7k
Other operating charges640/8€140€583
Gross operating margin9900€145k€114k
Operating profit (loss)9901€139k€106k
Financial income75/76B€15k€9k
Recurring financial income75€15k€9k
Financial charges65/66B€4k€7k
Recurring financial charges65€4k€7k
Profit (loss) for the period before taxes9903€150k€109k
Income taxes67/77€36k€24k
Profit (loss) for the period9904€114k€85k
Profit (loss) for the period to be appropriated9905€114k€85k
Appropriation of the result
Profit (loss) to be appropriated9906€114k€85k
Transfer from equity791/2€21k€375k
Transfer to equity691/2-€85k
To other reserves6921-€85k
Profit to be distributed694/7€135k€375k
Return on contributions (dividend)694€135k€375k

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
30-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
25-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Highest result since 2018net €118k ▲234%
Operating result €146k, net result €118k, both a record.
31-12
Financial Liquidity doublescurrent ratio 8.36
Current ratio from 3.38 to 8.36; short-term debt falls from €130k to €70k.
31-12
Financial Equity above €500kEq €507k ▲30.3%
6 profitable years in a row build equity to €507k.
27-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
04-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Equity above €200kEq €282k ▲89.7%
3 profitable years in a row build equity to €282k.
27-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial Liquidity doublescurrent ratio 4.06
Current ratio from 1.78 to 4.06.
31-12
Financial Equity above €100kEq €148k ▲220%
2 profitable years in a row build equity to €148k.
09-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Smedenstraat 202610 Antwerpen
Ground area
186 m²
Building footprint
93 m²
Volume, LiDAR
665 m³
Parcel 11462A0012/00L007, Flanders · tallest building 9.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Perpetuum Ventures
Smedenstraat 20, 2610 AntwerpenManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20182.277.575.143
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11462A0012/00L007 Flanders 185 m² 1 · 93 m² 9.0 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 798 companies in sector 46450 we hold annual accounts for 452. 333 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded18-01-2018
Fiscal year end31-12
Abbreviation NL Perpetuum
Activities, NACEBEL
46450Wholesale of perfume and cosmetics
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
64200Holdings
64210Activities of holding companies
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers

Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.